DAFNA Capital Management as of Dec. 31, 2023
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 76 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Spdr S&p Biotech Etf Etf (XBI) | 10.4 | $43M | 484k | 89.29 | |
Cytokinetics Com New (CYTK) | 8.0 | $33M | 400k | 83.49 | |
Stereotaxis Com New (STXS) | 5.7 | $24M | 14M | 1.75 | |
Ideaya Biosciences (IDYA) | 4.4 | $18M | 516k | 35.58 | |
Syndax Pharmaceuticals (SNDX) | 3.8 | $16M | 743k | 21.61 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 3.7 | $16M | 124k | 125.95 | |
Karuna Therapeutics Ord | 3.7 | $15M | 48k | 316.51 | |
Revolution Medicines (RVMD) | 3.5 | $15M | 512k | 28.68 | |
Ishares Nasdaq Biotech Indx Etf (IBB) | 3.3 | $14M | 103k | 135.85 | |
Xenon Pharmaceuticals (XENE) | 3.1 | $13M | 277k | 46.06 | |
Merus N V (MRUS) | 3.0 | $13M | 455k | 27.50 | |
Blueprint Medicines (BPMC) | 2.5 | $10M | 111k | 92.24 | |
Day One Biopharmaceuticals I (DAWN) | 2.4 | $10M | 687k | 14.60 | |
Neurocrine Biosciences (NBIX) | 2.3 | $9.6M | 73k | 131.76 | |
Dex (DXCM) | 2.0 | $8.4M | 68k | 124.09 | |
Kalvista Pharmaceuticals (KALV) | 1.8 | $7.4M | 601k | 12.25 | |
Biohaven (BHVN) | 1.7 | $7.2M | 169k | 42.80 | |
Kura Oncology (KURA) | 1.7 | $7.1M | 493k | 14.38 | |
Morphic Hldg (MORF) | 1.6 | $6.7M | 232k | 28.88 | |
Tandem Diabetes Care Com New (TNDM) | 1.6 | $6.5M | 221k | 29.58 | |
Axogen (AXGN) | 1.5 | $6.4M | 936k | 6.83 | |
2seventy Bio Common Stock (TSVT) | 1.5 | $6.2M | 1.4M | 4.27 | |
ImmunoGen | 1.4 | $5.7M | 194k | 29.65 | |
Sage Therapeutics (SAGE) | 1.3 | $5.3M | 245k | 21.67 | |
Galapagos Nv Spon Adr (GLPG) | 1.3 | $5.3M | 130k | 40.65 | |
Mirati Therapeutics | 1.3 | $5.3M | 89k | 58.75 | |
Edgewise Therapeutics (EWTX) | 1.2 | $4.9M | 449k | 10.94 | |
Alector (ALEC) | 1.2 | $4.9M | 610k | 7.98 | |
Viking Therapeutics (VKTX) | 1.1 | $4.6M | 248k | 18.61 | |
AtriCure (ATRC) | 1.1 | $4.5M | 126k | 35.69 | |
Arcus Biosciences Incorporated (RCUS) | 1.1 | $4.4M | 233k | 19.10 | |
Century Therapeutics (IPSC) | 1.0 | $4.3M | 1.3M | 3.32 | |
BioCryst Pharmaceuticals (BCRX) | 1.0 | $4.2M | 710k | 5.99 | |
Ascendis Pharma A/s Note 2.250% 4/0 (Principal) | 1.0 | $4.1M | 4.0M | 1.03 | |
Accuray Incorporated (ARAY) | 0.8 | $3.5M | 1.2M | 2.83 | |
Astria Therapeutics (ATXS) | 0.8 | $3.4M | 449k | 7.68 | |
Keros Therapeutics (KROS) | 0.7 | $3.0M | 74k | 39.76 | |
Acelyrin (SLRN) | 0.7 | $2.8M | 371k | 7.46 | |
Procept Biorobotics Corp (PRCT) | 0.6 | $2.7M | 63k | 41.91 | |
Mediwound Shs New (MDWD) | 0.6 | $2.6M | 258k | 10.17 | |
Bicycle Therapeutics Sponsored Ads (BCYC) | 0.5 | $2.2M | 122k | 18.08 | |
Brainsway Sponsored Ads (BWAY) | 0.5 | $2.0M | 309k | 6.48 | |
Proqr Therapeutics N V Shs Euro (PRQR) | 0.4 | $1.9M | 941k | 1.98 | |
Amylyx Pharmaceuticals (AMLX) | 0.4 | $1.8M | 123k | 14.72 | |
Mereo Biopharma Group Spon Ads (MREO) | 0.4 | $1.8M | 779k | 2.31 | |
Immunovant (IMVT) | 0.4 | $1.7M | 41k | 42.13 | |
Silverback Therapeutics (SPRY) | 0.4 | $1.7M | 311k | 5.48 | |
Compass Pathways Sponsored Ads (CMPS) | 0.4 | $1.7M | 193k | 8.75 | |
Syros Pharmaceuticals Com New (SYRS) | 0.4 | $1.7M | 215k | 7.79 | |
Spruce Biosciences (SPRB) | 0.4 | $1.6M | 549k | 2.93 | |
Larimar Therapeutics (LRMR) | 0.4 | $1.5M | 324k | 4.55 | |
Macrogenics (MGNX) | 0.4 | $1.5M | 152k | 9.62 | |
Regulus Therapeutics (RGLS) | 0.3 | $1.4M | 1.1M | 1.28 | |
Argen Se Sponsored Adr (ARGX) | 0.3 | $1.4M | 3.6k | 380.43 | |
Gossamer Bio (GOSS) | 0.3 | $1.3M | 1.5M | 0.91 | |
Cullinan Oncology (CGEM) | 0.3 | $1.3M | 127k | 10.19 | |
Autolus Therapeutics Spon Ads (AUTL) | 0.3 | $1.2M | 191k | 6.44 | |
Sutro Biopharma (STRO) | 0.3 | $1.2M | 283k | 4.29 | |
Immatics Nv SHS (IMTX) | 0.3 | $1.1M | 105k | 10.53 | |
Iteos Therapeutics (ITOS) | 0.3 | $1.1M | 99k | 10.95 | |
Neuronetics (STIM) | 0.2 | $910k | 314k | 2.90 | |
Oric Pharmaceuticals (ORIC) | 0.2 | $670k | 73k | 9.20 | |
Acrivon Therapeutics Common Stock (ACRV) | 0.2 | $646k | 131k | 4.92 | |
Nevro (NVRO) | 0.1 | $603k | 28k | 21.52 | |
Compugen Ord (CGEN) | 0.1 | $406k | 205k | 1.98 | |
Masimo Corporation (MASI) | 0.1 | $352k | 3.0k | 117.21 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.1 | $278k | 351k | 0.79 | |
Vigil Neuroscience (VIGL) | 0.1 | $243k | 72k | 3.38 | |
Elevation Oncology (ELEV) | 0.1 | $242k | 450k | 0.54 | |
Vistagen Therapeutics Ord (VTGN) | 0.1 | $215k | 42k | 5.14 | |
Spero Therapeutics (SPRO) | 0.0 | $184k | 125k | 1.47 | |
Compass Therapeutics (CMPX) | 0.0 | $182k | 117k | 1.56 | |
Karyopharm Therapeutics (KPTI) | 0.0 | $167k | 193k | 0.86 | |
Mineralys Therapeutics (MLYS) | 0.0 | $131k | 15k | 8.60 | |
Kinnate Biopharma | 0.0 | $119k | 50k | 2.37 | |
Inogen (INGN) | 0.0 | $82k | 15k | 5.49 |